Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients

被引:46
作者
Baumgartner, Annina [1 ]
Tausch, Christoph [2 ]
Hosch, Stefanie [2 ]
Papassotiropoulos, Barbel [2 ]
Varga, Zsuzsanna [3 ]
Rageth, Christoph [2 ]
Baege, Astrid [2 ,4 ]
机构
[1] Univ Zurich, Fac Med, Ramistr 71, CH-8008 Zurich, Switzerland
[2] Breast Ctr Zurich, Seefeldstr 214, CH-8008 Zurich, Switzerland
[3] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Ramistr 100, CH-8091 Zurich, Switzerland
[4] Univ Hosp Zurich, Dept Gynecol, Frauenklin Str 10, CH-8091 Zurich, Switzerland
关键词
Breast cancer; Breast ultrasound; Neoadjuvant chemotherapy; Pathologic response; Receptor subtypes; THERAPY; SURVIVAL; WOMEN; CONSERVATION; METAANALYSIS; MAMMOGRAPHY; INCREASES; SURROGATE; ACCURACY; SUBTYPES;
D O I
10.1016/j.breast.2018.02.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Accuracy in predicting pathologic response to neoadjuvant chemotherapy (NACT) in breast cancer is essential for the determination of therapeutic efficacy and surgical planning. This study aimed to assess the precision of ultrasound (US) for predicting pathologic complete response (pCR = ypT0) after NACT. Methods: This retrospective mono-center study included 124 invasive breast cancer patients treated with NACT. Patients received US before and after NACT with documentation of clinical partial response (cPR) and clinical complete response (cCR). Post-operatively, the pathologic response was defined as absence of tumor cells (ypT0), presence of non-invasive tumor cells (ypTis) or invasive tumor cells (ypTinv). Sensitivity and specificity of US as well as false negative rate (FNR), negative predictive value (NPV) and positive predictive value (PPV) were analysed for receptor subtypes. A multivariable logistic regression model assessed the influence of patient-and tumor-associated covariates as predictors for pCR. Results: 50 patients (40.3%) achieved pCR, 39 (78.0%) had a corresponding cCR. Overall sensitivity was 60.8% and specificity 78.0% for US-predicted remission. NPV and FNR differed substantially between subtypes. NPV was highest (75.0%) in triple negative (TN) subtype, while FNR was low (37.5%). Therefore, pathological response was most accurately predicted for TN cancers. NPV for human-epidermal-growth-factor-receptor-2-positive/hormone-receptor-positive (HER2+/HR+) was 55.6%, for HER2+/HR- 64.3% and for HER2-/HR+ 16.7%, FNRs were 40.0%, 71.4% and 32.3%, respectively. Receptor subtypes impacted pCR significantly (p-value: 0.0033), cCR correlated positively with pCR (p-value: 0.0026). Conclusion: US imaging is insufficient to predict pCR with adequate accuracy. Receptor subtypes, however, affect diagnostic precision of US and pathologic outcome. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:19 / 23
页数:5
相关论文
共 38 条
[1]  
Altman D.G., 1994, Practical statistics for medical research
[2]  
[Anonymous], 2001, In all likelihood: statistical modelling and inference using likelihood
[3]  
[Anonymous], 2016, R LANGUAGE ENV STAT
[4]   Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies [J].
Berruti, Alfredo ;
Amoroso, Vito ;
Gallo, Fabio ;
Bertaglia, Valentina ;
Simoncini, Edda ;
Pedersini, Rebecca ;
Ferrari, Laura ;
Bottini, Alberto ;
Bruzzi, Paolo ;
Sormani, Maria Pia .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) :3883-U288
[5]   The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer [J].
Clouth, B. ;
Chandrasekharan, S. ;
Inwang, R. ;
Smith, S. ;
Davidson, N. ;
Sauven, P. .
EJSO, 2007, 33 (08) :961-966
[6]   Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer [J].
Cortazar, Patricia ;
Geyer, Charles E., Jr. .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) :1441-1446
[7]   Accuracy of Clinical Examination, Digital Mammogram, Ultrasound, and MRI in Determining Postneoadjuvant Pathologic Tumor Response in Operable Breast Cancer Patients [J].
Croshaw, Randal ;
Shapiro-Wright, Hilary ;
Svensson, Erik ;
Erb, Kathleen ;
Julian, Thomas .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (11) :3160-3163
[8]   Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].
Fisher, B ;
Bryant, J ;
Wolmark, N ;
Mamounas, E ;
Brown, A ;
Fisher, ER ;
Wickerham, DL ;
Begovic, M ;
DeCillis, A ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV ;
Bear, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685
[9]  
Fox J., 2011, Applied Regression Analysis and Generalized Linear Models, V2
[10]   Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer [J].
Gianni, L ;
Zambetti, M ;
Clark, K ;
Baker, J ;
Cronin, M ;
Wu, J ;
Mariani, G ;
Rodriguez, J ;
Carcangiu, M ;
Watson, D ;
Valagussa, P ;
Rouzier, R ;
Symmans, WF ;
Ross, JS ;
Hortobagyi, GN ;
Pusztai, L ;
Shak, S .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7265-7277